DeviceClearance

Dexcom Pro Q Continuous Glucose Monitoring System— 510(k) K182405

Substantially Equivalent

Dexcom, Inc.

FDA 510(k) clearance K182405 for Dexcom Pro Q Continuous Glucose Monitoring System, Substantially Equivalent on 2018-11-02. Applicant: Dexcom, Inc..

Clearance details

Applicant
Dexcom, Inc.
Product code
Code QDL
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
San Diego, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.